News

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
Brenda Johnson, a beloved wife, mother and grandmother of Southill tragically passed away from pancreatic cancer in April last year, just ...
Amplia Therapeutics and Immutep have released clinical trial results that promise more effective treatments for pancreatic and lung cancers ...
Oncolytics Biotech Inc (ONCY) reports promising clinical data and strategic partnerships, while navigating leadership transitions and financial hurdles.
Finance Income, net was $1.0 million for the three months ended March 31, 2025, compared to $0.7 million in the same period ...
Memorial Day is a time to set aside our differences and join together in remembering and thanking those brave souls who gave ...
Operator: Good afternoon, and welcome to Oncolytics Biotech First Quarter Conference Call. All participants are in a listen-only mode.
GI Symposium data underscores pelareorep's clinical benefit in anal and pancreatic cancers Pelareorep featured in Key Opinion ...
Final CM24 Phase 2 data presented at AACR Annual Meeting 2025, strengthening patient selection strategy for CM24 Phase 2b study planned to be initiated in Second Half of 2025 NT219 data presented at ...
Jen Duguid Savader taught Family & Consumer Science for years at Fairfield Woods and Tomlinson middle schools. She died last ...
Food security remains a critical challenge, and AI is helping to shape the future of sustainable farming. In collaboration ...